Eli Lilly and Novo Nordisk Compete in the Growing Obesity Drug Market
The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working […]
Browsing category
The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working […]
Over the next five years, many top-selling cancer drugs from major pharmaceutical companies will lose their patent protection. This is […]
A report from the Make America Healthy Again (MAHA) Commission was delayed earlier this month, but leaked documents reveal plans […]
Measuring how long a cancer treatment extends life (overall survival, or OS) is the best way to judge its effectiveness. […]
The US Food and Drug Administration (FDA) has given special recognition to a new experimental drug called izalontamab brengitecan (iza-bren). […]
Gilead’s Kite Pharma has agreed to purchase Interius BioTherapeutics for $350 million. This deal will help Kite expand its work […]
Anne White, the Executive Vice President and President of Lilly Neuroscience at Eli Lilly and Company, will retire at the […]
Eli Lilly is looking for a new leader for its neuroscience division after announcing that Anne White, the current head, […]
In this project, ANGLE’s research team will use the Parsortix system to collect cancer cells from the blood of cancer […]
Johnson & Johnson (J&J) has made a major move to strengthen its US manufacturing operations by signing a $2 billion, […]